Coste Catherine 4
4 · BIOMERICA INC · Filed Dec 11, 2023
Insider Transaction Report
Form 4
BIOMERICA INCBMRA
Coste Catherine
Director
Transactions
- Award
Non-qualified stock option
2023-04-20+32,000→ 32,000 totalExercise: $1.67From: 2023-12-07Exp: 2033-04-20→ Common Stock (32,000 underlying)
Holdings
- 43,790
Common stock
Footnotes (2)
- [F1]Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
- [F2]Not Applicable